Exopharm

By

“The biggest problem is to purify the EVs from their source and to eliminate the contaminants, and not damage the EVs,” says Managing Director and founder Dr Ian Dixon.

One of the great things about our LEAP technology and process is that it is scalable.

You can read the full Stockhead article here.